TMO

Thermo Fisher Scientific
D

TMO

Arincen67/100B
706.32
USD
7.96
(1.14%)
Post Trading·709.98USD+3.66(+0.52%)
Last updated: · Delayed 15 min
Fair value599.09Plus+18%433Price 706.32754
Q4 FY2026 · Earnings report
EPS estimate 7.13Revenue estimate 12.84B
OverviewFinancialsForecastEarningsDividendsCompany

Thermo Fisher Scientific stock forecast 2026–2030

Analysts' average 12-month price target for Thermo Fisher Scientific is 694.27, 1.7% below the current price of 706.32. Their targets range from 520.00 to 800.00.

Of the 13 firms that rated Thermo Fisher Scientific in the past 12 months, 10 rate it buy or strong buy, 3 hold and 0 sell or strong sell (each firm at its latest rating); on average they come to Buy.

12-month price target
694.27 USD
-1.71%

Analysts' 1-year price targets range from 520.00 to 800.00, with an average of 694.27.

Past year
1-year forecast
Strong sellStrong buy
Buy
13 ratings
Strong buy
0
Buy
10
Hold
3
Sell
0
Strong sell
0

12-month price target

Highest target800.00
Average target694.27
Lowest target520.00
Current price706.32

Thermo Fisher Scientific price target history

Have analysts recently raised or lowered their Thermo Fisher Scientific price target and rating?

See how analysts moved their price target

How analysts rate Thermo Fisher Scientific, month by month

10 of 13 firms rate it buy now, against 16 of 17 in December 2025.

Buy Hold Sell

Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.

Month endBuyHoldSellFirms
Nov 2026103013
Oct 2026103013
Sept 2026124016
Aug 2026124016
Jul 2026124016
Jun 2026142016
May 2026151016
Apr 2026151016
Mar 2026161017
Feb 2026161017
Jan 2026161017
Dec 2025161017

Thermo Fisher Scientific analyst upgrades, downgrades and price targets

The latest rating change came on 3 June 2026, when HSBC downgraded Thermo Fisher Scientific from Buy to Hold. Its price target is 540.00. The most recent new target came from Argus Research on 30 October 2026: 780.00.

DateFirmRatingPrice targetChangePrice then
30 Oct 2026
Argus Research
David Toung
Reiterated · Buy780.00—709.18
22 Oct 2026
UBS
Douglas Schenkel
—730.00 → 800.00+9.6%686.55

Thermo Fisher Scientific EPS and revenue estimates

Analysts expect Thermo Fisher Scientific's EPS to grow 20.0% a year until 2028, faster than over the last 5 years (2.1% a year) and the last 3 years (0.2%).

Analysts expect Thermo Fisher Scientific's revenue to grow 6.5% a year until 2028. Over the last 5 years it grew 6.7% a year, and over the last 3 years it fell 0.3%.

Revenue

ReportedEstimate

EPS

ReportedEstimate
Fiscal yearEPSEPS growthEPS rangeRevenueRevenue growthRevenue rangeAnalysts
FY2028 (est.) 30.63+10.4%27.39 – 32.37 53.76B+6.3%52.97B – 55.51B6
FY2027 (est.) 27.74+9.7%26.93 – 29.22 50.57B+5.3%50.33B – 51.08B16
FY2026 (est.) 25.29+10.6%25.18 – 25.43 48.00B+7.7%47.80B – 48.18B15
FY2025 22.87+4.6%— 44.56B+3.9%——
FY2024 21.86+1.5%— 42.88B+0.1%——
FY2023 21.54-7.3%— 42.86B-4.6%——
FY2022 23.24—— 44.92B———

Does Thermo Fisher Scientific beat earnings estimates?

On average, analysts' EPS estimate was 3.4% off the result, either way, and their revenue estimate 1.4%, over the last 12 quarters.

EPS beats
111 / 136
Revenue beats
99 / 113
Average EPS surprise, last 12
+3.4%
Since
March 1993
QuarterReport dateEPS estimateReported EPSSurpriseRevenue estimateReported revenueSurprise
Q3 FY202621 Oct 20266.406.68+4.4%11.95B12.14B+1.5%
Q2 FY202623 Jul 20265.726.03+5.4%11.71B11.99B+2.5%
Q1 FY202623 Apr 20265.255.44+3.6%10.86B11.01B+1.3%
Q4 FY202529 Jan 20266.456.57+1.9%11.95B12.22B+2.2%
Q3 FY202522 Oct 20255.505.79+5.3%10.92B11.12B+1.9%
Q2 FY202523 Jul 20255.235.36+2.5%10.68B10.86B+1.6%
Q1 FY202523 Apr 20255.105.15+1.0%10.23B10.36B+1.3%
Q4 FY202430 Jan 20255.946.10+2.7%11.28B11.40B+1.0%
Q3 FY202423 Oct 20245.255.28+0.6%10.63B10.60B-0.3%
Q2 FY202424 Jul 20245.125.37+4.9%10.50B10.54B+0.3%
Q1 FY202424 Apr 20244.715.11+8.5%10.15B10.35B+1.9%
Q4 FY202331 Jan 20245.645.67+0.5%10.73B10.89B+1.5%

Thermo Fisher Scientific stock price 2026–2030: scenarios

If Thermo Fisher Scientific's earnings keep growing at the 10.2% a year analysts expect to FY2028, it would earn about 37.21 a share in FY2030. At the P/E it has traded at over the last five years (31.1 to 34.2) that is 1,155.81 to 1,271.86 a share, or 1,214.98 at its average P/E of 32.6. This is arithmetic on the analysts' estimates, not a prediction.

Bull Base Bear
Fiscal yearEPSBearBaseBull
FY2026 25.29785.36825.56864.21
FY2027 27.74861.60905.71948.11
FY2028 30.63951.301,000.001,046.82
FY2029 (extrapolated)33.761,048.581,102.261,153.87
FY2030 (extrapolated)37.211,155.811,214.981,271.86

Each year's EPS is the analysts' consensus to FY2028; the years after continue its 10.2% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (31.1, 32.6, 34.2).

Is Thermo Fisher Scientific stock undervalued or overvalued?

Thermo Fisher Scientific's P/E of 37.2 is near the top of its 5-year range (22.8 to 39.7, median 31.5). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay less for each point of growth than usual: a PEG of 1.9 on expected growth against 14.9 on its median P/E and past five years' growth. At its usual P/E (31.5 × EPS of 18.99), Thermo Fisher Scientific's fair value is 599.09; the price, 706.32, is ⁦17.9%⁩ above it. Its forward P/E, on the consensus for FY2026, is 27.9.

The price against its fair value
Fair value 599.09Price 706.32433.41754.00

Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (22.8 and 39.7). The price against its P/E range

Price to earnings ratio (TTM)
37.19
Five-year median P/E
31.55
Five-year P/E range
22.8 – 39.7
Forward P/E (FY2026)
27.93
PEG ratio
3.64
To the average target
-1.7%
See the full P/E history check Plus

Most undervalued US stocks

StockPriceFair valueUpside
66.390
128.2462Price 66.39185
+93.2%
101.860
195.27146Price 101.86244
+91.7%
123.790
235.44177Price 123.79294
+90.2%
200.280
359.04269Price 200.28449
+79.3%
227.150
406.28305Price 227.15508
+78.9%
159.100
284.37213Price 159.10355
+78.7%
105.320
175.76132Price 105.32220
+66.9%

Furthest below the fair value on each stock's page, updated every day.

Common questions about the Thermo Fisher Scientific stock forecast

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.